Patents by Inventor Ivan Perez
Ivan Perez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230330157Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: ApplicationFiled: May 17, 2023Publication date: October 19, 2023Applicant: Eligo BioscienceInventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Publication number: 20230287415Abstract: The present invention relates to a pharmaceutical composition comprising a LCoR activator and an immune checkpoint inhibitor (ICI), to its use in the treatment of cancer and to the use of LCoR as marker of response to immunotherapy in cancer treatment.Type: ApplicationFiled: July 23, 2021Publication date: September 14, 2023Inventors: Antoni CELIÀ TERRASSA, Joan ALBANELL MESTRES, Catalina ROZALÉN MIRALLES, Iván PÉREZ NÚÑEZ
-
Publication number: 20230226129Abstract: The invention relates to methods, kits and compositions for reducing the level of or eliminating Bacteroides in situ. The invention encompasses methods of preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof, comprising reducing the amount of Bacteroides sp. in the subject. The invention further encompasses methods of diagnosis of a subject as having myocarditis or dilated cardiomyopathy. The invention also encompasses compositions preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof.Type: ApplicationFiled: January 25, 2023Publication date: July 20, 2023Inventors: Xavier Duportet, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig
-
Patent number: 11690880Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: GrantFiled: November 3, 2022Date of Patent: July 4, 2023Assignee: Eligo BioscienceInventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Publication number: 20230113800Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: ApplicationFiled: November 3, 2022Publication date: April 13, 2023Applicant: Eligo BioscienceInventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Patent number: 11617773Abstract: The invention relates to methods, kits and compositions for reducing the level of or eliminating Bacteroides in situ. The invention encompasses methods of preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof, comprising reducing the amount of Bacteroides sp. in the subject. The invention further encompasses methods of diagnosis of a subject as having myocarditis or dilated cardiomyopathy. The invention also encompasses compositions preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof.Type: GrantFiled: April 8, 2021Date of Patent: April 4, 2023Assignees: Eligo Bioscience, Kantonsspital St.GallenInventors: Xavier Duportet, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig
-
Patent number: 11534467Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: GrantFiled: April 8, 2022Date of Patent: December 27, 2022Assignee: Eligo BioscienceInventors: Xavier Duportet, Antoine Decrulle, Cristina Del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Publication number: 20220233610Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: ApplicationFiled: April 8, 2022Publication date: July 28, 2022Applicant: Eligo BioscienceInventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Patent number: 11376286Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: GrantFiled: October 14, 2021Date of Patent: July 5, 2022Assignee: ELIGO BIOSCIENCEInventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Publication number: 20220166900Abstract: A method of calibrating a printing device, wherein the method comprises: associating a weighted printing value to each of a plurality of pixels, wherein associating a weighted printing value to each pixel comprises: obtaining, from a first calibration table, a first calibration value; obtaining, from a second calibration table, a second calibration value; obtaining first and second weighting factors, wherein the first weighting factor is obtained from a weighting table, generating the weighted printing value as the sum of the first calibration value weighted with the first weighting factor and the second calibration value weighted with the second weighting factor.Type: ApplicationFiled: July 15, 2019Publication date: May 26, 2022Applicant: Hewlett-Packard Development Company, L.P.Inventors: Carlos Fajardo Sanchez, Joan Vidal Fortia, Ivan Perez Laka
-
Publication number: 20220132000Abstract: Certain examples relate to converting between color spaces. A digital representation of an input color is pre-processed to convert the digital representation into a multidimensional node representing a region in the input color space and a set of adjustment values. The multidimensional node is mapped to a digital representation of an output color. The digital representation of the output color is adjusted using the set of adjustment values.Type: ApplicationFiled: July 10, 2019Publication date: April 28, 2022Applicant: Hewlett-Packard Development Company, L.P.Inventors: Carlos Fajardo Sanchez, Joan Vidal Fortia, Ivan Perez Laka
-
Publication number: 20220031767Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: ApplicationFiled: October 14, 2021Publication date: February 3, 2022Applicant: Eligo BioscienceInventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Patent number: 11224621Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: GrantFiled: April 8, 2021Date of Patent: January 18, 2022Assignee: ELIGO BIOSCIENCEInventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Publication number: 20210315944Abstract: The invention encompasses compositions, kits and methods for modifying bacteria, preferably naturally occurring bacteria, in situ. These can be used to treat, prevent or cure microbiome-associated diseases or disorders by modulating the molecules expressed and/or secreted by bacterial populations of the microbiome in a specific manner. The genomic modifications can modify the interactions between part or all of these populations and the host in a way that decreases their deleterious potential on host health. The compositions, kits and methods of the invention do not result in the direct death of these populations or a direct significant inhibition of their growth. The invention further includes methods for screening for genetic modifications in the bacteria, for determining the efficiency of vectors at inducing these genetic mutations, and for determining the effects of these mutations on bacterial growth.Type: ApplicationFiled: April 8, 2021Publication date: October 14, 2021Inventors: Xavier Duportet, Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez, Andreas Brodel
-
Publication number: 20210315950Abstract: The invention relates to methods, kits and compositions for reducing the level of or eliminating Bacteroides in situ. The invention encompasses methods of preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof, comprising reducing the amount of Bacteroides sp. in the subject. The invention further encompasses methods of diagnosis of a subject as having myocarditis or dilated cardiomyopathy. The invention also encompasses compositions preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof.Type: ApplicationFiled: April 8, 2021Publication date: October 14, 2021Inventors: Xavier Duportet, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig
-
Patent number: 10116837Abstract: Examples relate to providing synchronized look-up table loading. In some examples, a print job is processed using an initial look-up table in processor memory. In response to the processing of the print job reaching a buffer trigger row of a portion of the print job, look-up metadata is accessed to locate a next look-up table. At this stage, the next look-up table is dynamically loaded into the processor memory as the processor continues to process the print job, where the processing of the print job begins using the next look-up table after a target row of the portion of the print job is reached.Type: GrantFiled: December 13, 2017Date of Patent: October 30, 2018Assignee: Hewlett-Packard Development Company, L.P.Inventors: Joan Vidal Fortia, Ivan Perez Laka, Fernando Viciano Martin
-
Publication number: 20180103181Abstract: Examples relate to providing synchronized look-up table loading. In some examples, a print job is processed using an initial look-up table in processor memory. In response to the processing of the print job reaching a buffer trigger row of a portion of the print job, look-up metadata is accessed to locate a next look-up table. At this stage, the next look-up table is dynamically loaded into the processor memory as the processor continues to process the print job, where the processing of the print job begins using the next look-up table after a target row of the portion of the print job is reached.Type: ApplicationFiled: December 13, 2017Publication date: April 12, 2018Applicant: HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.Inventors: Joan Vidal Fortia, Ivan Perez Laka, Fernando Viciano Martin
-
Patent number: 9883081Abstract: Examples relate to providing synchronized look-up table loading. In some examples, a print job is processed using an initial look-up table in processor memory, in response to the processing of the print job reaching a buffer trigger row of a portion of the print job, look-up metadata is accessed to locate a next look-up table. At this stage, the next look-up table is dynamically loaded into the processor memory as the processor continues to process the print job, where the processing of the print job begins using the next look-up table after a target row of the portion of the print job is reached.Type: GrantFiled: May 30, 2014Date of Patent: January 30, 2018Assignee: Hewlett-Packard Development Company, L.P.Inventors: Joan Vidal Fortia, Ivan Perez Laka, Fernando Viciano Martin
-
Publication number: 20170085754Abstract: Examples relate to providing synchronized look-up table loading. In some examples, a print job is processed using an initial look-up table in processor memory, in response to the processing of the print job reaching a buffer trigger row of a portion of the print job, look-up metadata is accessed to locate a next look-up table. At this stage, the next look-up table is dynamically loaded into the processor memory as the processor continues to process the print job, where the processing of the print job begins using the next look-up table after a target row of the portion of the print job is reached.Type: ApplicationFiled: May 30, 2014Publication date: March 23, 2017Applicant: HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.Inventors: Joan Vidal Fortia, Ivan Perez Laka, Fernando Viciano Martin
-
Patent number: 9242136Abstract: An exercise assembly for selectively providing resistance to a user's hand includes an article of apparel that may be worn on a user's hand. A resistance band is operationally coupled to the article of apparel. A handle is operationally coupled to the article of apparel. The handle is coupled to the resistance band. The handle selectively places the resistance band in a resisting position. The resistance band provides resistance to the user's hand.Type: GrantFiled: October 8, 2013Date of Patent: January 26, 2016Inventor: Ivan Perez